1. Home
  2. HUMA vs FOF Comparison

HUMA vs FOF Comparison

Compare HUMA & FOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • FOF
  • Stock Information
  • Founded
  • HUMA 2004
  • FOF 2006
  • Country
  • HUMA United States
  • FOF United States
  • Employees
  • HUMA N/A
  • FOF N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • FOF Investment Managers
  • Sector
  • HUMA Health Care
  • FOF Finance
  • Exchange
  • HUMA Nasdaq
  • FOF Nasdaq
  • Market Cap
  • HUMA 250.2M
  • FOF 354.8M
  • IPO Year
  • HUMA N/A
  • FOF N/A
  • Fundamental
  • Price
  • HUMA $1.51
  • FOF $13.04
  • Analyst Decision
  • HUMA Strong Buy
  • FOF
  • Analyst Count
  • HUMA 8
  • FOF 0
  • Target Price
  • HUMA $10.88
  • FOF N/A
  • AVG Volume (30 Days)
  • HUMA 5.9M
  • FOF 58.7K
  • Earning Date
  • HUMA 08-11-2025
  • FOF 01-01-0001
  • Dividend Yield
  • HUMA N/A
  • FOF 9.07%
  • EPS Growth
  • HUMA N/A
  • FOF N/A
  • EPS
  • HUMA N/A
  • FOF N/A
  • Revenue
  • HUMA $818,000.00
  • FOF N/A
  • Revenue This Year
  • HUMA N/A
  • FOF N/A
  • Revenue Next Year
  • HUMA $949.92
  • FOF N/A
  • P/E Ratio
  • HUMA N/A
  • FOF N/A
  • Revenue Growth
  • HUMA N/A
  • FOF N/A
  • 52 Week Low
  • HUMA $1.15
  • FOF $9.59
  • 52 Week High
  • HUMA $6.77
  • FOF $11.75
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 36.87
  • FOF 58.11
  • Support Level
  • HUMA $1.43
  • FOF $13.01
  • Resistance Level
  • HUMA $1.67
  • FOF $13.13
  • Average True Range (ATR)
  • HUMA 0.15
  • FOF 0.09
  • MACD
  • HUMA -0.01
  • FOF -0.01
  • Stochastic Oscillator
  • HUMA 23.32
  • FOF 59.05

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About FOF Cohen & Steers Closed-End Opportunity Fund Inc.

Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. Its investment objective is to achieve a total return, consisting of high current income and potential capital appreciation.

Share on Social Networks: